[Research progress in tigliane-type macrocyclic diterpenoids].

bioactivities chemical structure drug development macrocyclic diterpenoids tigliane type

Journal

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
ISSN: 1001-5302
Titre abrégé: Zhongguo Zhong Yao Za Zhi
Pays: China
ID NLM: 8913656

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 9 10 2023
pubmed: 7 10 2023
entrez: 6 10 2023
Statut: ppublish

Résumé

Tigliane type macrocyclic diterpenoids with special structures and diverse bioactivities are mainly extracted from plants of Euphorbiaceae and Thymelaeaceae. According to the different functional groups, they can be classified into types of phorbol esters, C-4 deoxyphorbol esters, C-12 deoxyphorbol esters, C-16 or C-17 substituted phorbol esters and others. Most of them present promising antiviral activities and cytotoxic activities and are expected to be developed as candidates for anti-AIDS, anti-tuberculosis, and anti-tumor clinical trials, demonstrating great potential for the application in healthcare. This paper reviews 115 novel tigliane-type diterpenoids discovered since 2013 and summarize their chemical structures and bioactivities, aiming to lay a foundation for further development and utilization of these compounds and provide new ideas for the development of clinical drugs.

Identifiants

pubmed: 37802801
doi: 10.19540/j.cnki.cjcmm.20230427.201
doi:

Substances chimiques

Phorbols 0
Diterpenes 0
Antiviral Agents 0
Phorbol Esters 0

Types de publication

Review English Abstract Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

4620-4633

Auteurs

Hong-Hu Tan (HH)

State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023, China.

Meng Xia (M)

State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.

Ping Su (P)

State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.

Lu-Qi Huang (LQ)

State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023, China.

Articles similaires

Animals Swine Antiviral Agents Swine Diseases Coronavirus Infections
Humans Carcinoma, Hepatocellular Liver Neoplasms Aged United States
Drug Repositioning Humans SARS-CoV-2 COVID-19 Drug Treatment Antiviral Agents

Nirmatrelvir plus ritonavir reduces COVID-19 hospitalization and prevents long COVID in adult outpatients.

Fatemeh Saheb Sharif-Askari, Hawra Ali Hussain Alsayed, Narjes Saheb Sharif-Askari et al.
1.00
Ritonavir Humans Female Male Middle Aged

Classifications MeSH